comparemela.com

Latest Breaking News On - Ntelgenx - Page 2 : comparemela.com

IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Results

SAINT LAURENT, Quebec, March 29, 2023 IntelGenx Technologies Corp. today reported financial results for the three- and twelve-month periods ended December 31, 2022. All dollar. | March 29, 2023

United statesSaint laurentMontelukast versafilmStephen kilmerHorstg zerbeAndre godinPharmaceuticals industries lebanonExchange commissionCompany or intelgenxKarolinska instituteSecurities exchangeIntelgenx corpTrademark officeLife sciencesCompany vetafilmUniversity of prince edward island

INTELGENX TECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)

Item 1.01 Entry Into a Material Definitive Agreement. On March 21, 2023 , IntelGenx Technologies Corp. closed an offering by way of private placement in the United States of unsecured. | March 24, 2023

United statesIntelgenx technologies corpCompany the commonCantone research incPlacement for the company rizaportMaterial definitiveGenx technologiesBeach noteClosing datePrivate placementPlacement agent warrantsCommon sharesConversion priceCurrent reportDirect financial obligationOff balance sheet arrangement

IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent

SAINT LAURENT, Quebec, Feb. 21, 2023 IntelGenx Corp. , a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office has granted a Notice of. | February 21, 2023

United statesSaint laurentStephen kilmerIntelgenx loxapine versafilmLoxapine versafilmAndre godinHorstg zerbeExchange commissionTrademark officeIntelgenx technologies corpCompany or intelgenxIntelgenx corpSecurities exchangeUnited states patentFilm oral dosage formIntelgenx loxapine

vimarsana © 2020. All Rights Reserved.